ResearcherFirst Affiliated Hospital of Anhui Medical UniversityNo recent work listed

Lianzi Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4694-6817; OpenAlex author ID A5082177078. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreati… Co-author DOI 10.1186/s12885-021-08550-9 ↗
Prognostic Value of m6A RNA Methylation Modulators and Potential Clinical Application in Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-43695/v1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuanhong Xu · 2 shared papers, 2020–2021 · strength 0.25
- Paper Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tu… DOI 10.1186/s12885-021-08550-9 ↗
- Paper Prognostic Value of m6A RNA Methylation Modulators and Potential Clinical Application in Pancreatic Cancer DOI 10.21203/rs.3.rs-43695/v1 ↗
Shubing Zhang · 1 shared paper, 2021 · strength 0.14
- Paper Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tu… DOI 10.1186/s12885-021-08550-9 ↗
shubing Zhang · 1 shared paper, 2020 · strength 0.11
- Paper Prognostic Value of m6A RNA Methylation Modulators and Potential Clinical Application in Pancreatic Cancer DOI 10.21203/rs.3.rs-43695/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.